CanVeer Biopharma
Where this team pitched, and the people named on it.
developing a first-in-class therapeutic for bronchopulmonary dysplasia in newborns
Where this team pitched, and the people named on it.
developing a first-in-class therapeutic for bronchopulmonary dysplasia in newborns